Patent IE-841484-L (IE)
Title: 13-alpha-alkyl-gonanes
IPC: A61K31/565
Filed: 1984-06-14
Abstract: 1. Claims for the Contracting States BE, CH, LI, DE, FR, GB, IT, LU, NL, SE 13 alpha-Alkyl gonanes of general formula I see diagramm : EP0129499,P14,F3 wherein R**1 means -N R**II -R**I wherein R**I and R**II are hydrogen or alkyl of 1-4 carbon atoms, or R**I and R**II with inclusion of N mean a saturated 5- or 6-membered ring, wherein the ring can contain, besides N, still another hetero atom, such as O, N, S, as well as the corresponding tertiary N-oxides and the acid addition salts, OR**III wherein R**III means methyl, ethyl, propyl, methoxyphenyl, allyl, or beta-dimethylaminoethyl, R**2 means a hydrogen atom, a methyl group or an ethyl group, R**3 means -(CH2 )n -CH3 with n=0-4, -(CH2 )n -CH2 -O(S)R**IV with n=0-4, and R**IV meaning hydrogen or alkyl of 1-4 carbon atoms, -CH=CH-(CH2 )n -OR**V with n=1-4, and R**V meaning hydrogen, alkyl, or alkanoyl of respectively 1-4 carbon atoms, -C -= C-X wherein X means hydrogen, alkyl of 1-4 carbon atoms, or halogen, -(CH2 )n -CH2 CN with n=0-3 or see diagramm : EP0129499,P14,F4 wherein Y means hydrogen or OR**V , R**4 is hydroxy, alkoxy, or alkanoyloxy of respectively 1-4 carbon atoms or R**3 /R**4 means see diagramm : EP0129499,P14,F2 wherein R**3 is in the alpha-position and R**4 is in the beta-position, or R**3 is in the beta-position and R**4 is in the alpha-position with respect to the steroid skeleton, and R**5 is a hydrogen atom or an alpha- or beta-positioned alkyl group of 1-4 carbon atoms. 1. Claim for the Contracting State AT Process for the preparation of 13 alpha-alkylgonanes of the general formula I see diagramm : EP0129499,P15,F4 wherein R**1 represents -N R**II -R**I , wherein R**I and R**II represent hydrogen or alkyl having from 1 to 4 carbon atoms, or R**I and R**II , with the inclusion of N, represent a saturated 5- or 6-membered ring, wherein the ring can contain, in addition to N, a further hetero atom, such as O, N or S, as well as the corresponding tertiary N-oxides and the acid addition salts, or represents -OR**III , wherein R**III represents methyl, ethyl, propyl, methoxyphenyl, allyl or beta-dimethylaminoethyl, R**2 represents a hydrogen atom, a methyl group or an ethyl group, R**3 represents -(CH2 )n -CH3 , where n=0-4, -(CH2 )n -CH2 -O(S)R**IV , where n=0-4 and R**IV represents hydrogen or alkyl having from 1 to 4 carbon atoms, -CH=CH-(CH2 )n -OR**V , where n=1-4 and R**V represents hydrogen, alkyl or alkanoyl each having from 1 to 4 carbon atoms, -C -= C-X, where X represents hydrogen, alkyl having from 1 to 4 carbon atoms, or halogen, -(CH2 )n -CH2 CN, where n=0-3, or see diagramm : EP0129499,P15,F7 where Y represents hydrogen or OR**V , where R**V has the meanings given above, R**4 represents hydroxy, alkoxy or alkanoyloxy each having from 1 to 4 carbon atoms, or R**3 /R**4 represents see diagramm : EP0129499,P16,F1 wherein R**3 is in the alpha-position and R**4 is in the beta-position, or R**3 is in the beta-position and R**4 is in the alpha-position with respect to the steroid skeleton, and R**5 represents a hydrogen atom or an alkyl group in the alpha- or beta-position having from 1 to 4 carbon atoms, characterised in that a compound of the general formula II see diagramm : EP0129499,P16,F3 wherein R**1 , R**2 and R**5 have the meanings given in formula I and Z is an ethylene or 2,2-dimethylpropylene group, is irradiated with ultraviolet light, and the 13-episteroid, obtained by UV irradiation, of the general formula III see diagramm : EP0129499,P16,F2 wherein R**1 , R**2 , R**5 and Z have the meanings given in formula II, is converted into the compounds of the general formula I in accordance with methods known per se by nucleophilic addition to the 17-ketone, cleavage of the 3-ketal protective group, and splitting off of water from the 4,5-position.
[EP0129499A2]